Completed NA INTERVENTIONAL 2-arm NCT00673894

Effects of Glutamine on GLP-1 and Insulin Secretion in Man

Study of the Effects of Glutamine on Glycemia, Glucagon-like Peptide-1 (GLP-1) and Insulin Secretion in Man

Sponsor: Garvan Institute of Medical Research

Updated 6 times since 2017 Last updated: Feb 11, 2019 Started: Apr 30, 2008 Primary completion: Dec 31, 2011 Completion: Nov 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Type 2 Diabetes, this trial is completed. The trial is conducted by Garvan Institute of Medical Research and has accumulated 6 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2019 — Jan 2021 [monthly]

Completed NA

Status: Unknown Status → Completed · Phase: PHASE1 → NA
Jun 2018 — Jun 2019 [monthly]

Unknown Status PHASE1

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE1

First recorded

Apr 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Garvan Institute of Medical Research

Data source: Garvan Institute of Medical Research

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Sydney, Australia